(18) F-FDG PET/CT for initial staging in breast cancer patients - Is there a relevant impact on treatment planning compared to conventional staging modalities?

OBJECTIVE: To evaluate the impact of whole-body (18) F-FDG PET/CT on initial staging of breast cancer in comparison to conventional staging modalities. METHODS: This study included 102 breast cancer patients, 101 patients were eligible for evaluation. Preoperative whole-body staging with PET/CT was performed in patients with clinical stage ≥ T2 tumours or positive local lymph nodes (n = 91). Postoperative PET/CT was performed in patients without these criteria but positive sentinel lymph node biopsy (n = 10). All patients underwent PET/CT and a conventional staging algorithm, which included bone scan, chest X-ray and abdominal ultrasound. PET/CT findings were compared to conventional staging and the impact on therapeutic management was evaluated. RESULTS: PET/CT led to an upgrade of the N or M stage in overall 19 patients (19 %) and newly identified manifestation of breast cancer in two patients (2 %). PET/CT findings caused a change in treatment of 11 patients (11 %). This is within the range of recent studies, all applying conventional inclusion criteria based on the initial T and N status. CONCLUSIONS: PET/CT has a relevant impact on initial staging and treatment of breast cancer when compared to conventional modalities. Further studies should assess inclusion criteria beyond the conventional T and N status, e.g. tumour grading and receptor status. KEY POINTS: • PET/CT may be relevant in staging breast cancer patients at higher risk for metastases • PET/CT may modify the N and M stage in multiple patients • PET/CT may impact treatment planning in breast cancer patients.

Do structural changes in the tumour bed after intraoperative radiotherapy (IORT) of breast cancer complicate the evaluation of mammograms in a long-term follow-up?

The purpose of the study was to assess whether postoperative changes in the tumour bed after intraoperative radiotherapy (IORT) with low-energy X-rays complicate the mammographic evaluation. 54 patients receiving breast-conserving surgery and IORT were compared to a control group of 48 patients with conventional breast-conserving treatment. All patients were included in routine follow-ups (≥3 years) with mammography accompanied by ultrasound. By retrospective consensus reading the mammographic changes in the tumour bed were classified as absent, low or distinct. Using the same grading it was classified whether mammographic evaluation was complicated due to postoperative changes. Focusing the yearly follow-ups within a period of four years, distinct changes were found significantly more often after IORT (52-62% vs. 7-30%). After IORT the evaluation was significantly more often distinctly complicated in each follow-up, except for year 1 (16-21% vs. 0-8%). In the IORT group the distribution of findings was nearly stable over time. In the control group it changed over time and a distinctly complicated evaluation was no longer seen in the follow-ups of years 3 and 4. Overall, further non-routine diagnostic procedures due to unclear findings in the tumour bed became necessary in 7% (IORT) vs. 8% (control group) of the patients (p=0.86). Evaluation of mammograms is complicated after IORT. In contrast to conventionally treated patients postoperative changes and difficulties of evaluation do not decrease over time. Overall, after IORT the diagnostic uncertainty does not seem to be increased in ultrasound supported mammographic follow-ups. The topic needs further evaluation with larger study samples.

Blood volume flow quantification of the brain-supplying circulation in fibromuscular dysplasia using 2D cine phase-contrast MRI.

To determine blood volume flow (BVF) in the brain-supplying arteries in patients with fibromuscular dysplasia (FMD), we used two-dimensional cine phase-contrast MR blood flow quantification to evaluate haemodynamic compromise. Nine patients with angiographically proven FMD (mean age, 46.7+/-10.4 years) of the cervical and intracranial arteries were examined using two-dimensional phase contrast MR to measure blood flow in the carotid arteries and the basilar artery (BA). Quantitative BVF results were compared intra- and inter-individually and also with the results of 15 age-matched normal controls. No patient showed evidence of acute or chronic infarction of the brain. FMD lesions were found in a total of 19 arteries (internal carotid artery: n = 14; vertebral arteries: n = 5). Five patients demonstrated severe stenoses of cervical vessels; four patients showed only mild or up to moderate stenoses. Total brain BVF in all FMD patients reached high-normal values compared with normal controls (747+/-64 ml min(-1) vs 682+/-38 ml min(-1)). In the five patients with severe stenotic lesions, blood flow was reduced in stenotic vessels and higher in the non-haemodynamically relevant stenosed cervical vessels. BVF was normal in the four patients with mild and moderate stenoses. By quantifying blood flow, we demonstrated for the first time changes (which can be severe) in the BVF of the brain-supplying arteries in FMD. Individual differences are associated with the haemodynamic relevance of the FMD lesions. Total BVF in patients with severe FMD was not decreased but maintained or even increased, possibly as an overcompensation.